Mukherjee, Jean
Ondeck, Celinia A.
Tremblay, Jacqueline M.
Archer, Jacob
Debatis, Michelle
Foss, Alexa
Awata, Junya
Erasmus, Jesse H.
McNutt, Patrick M.
Shoemaker, Charles B.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI125704)
Defense Advanced Research Projects Agency (HROO11-14-2-0005 subaward 10-1798-9902)
Article History
Received: 16 April 2022
Accepted: 30 June 2022
First Online: 8 July 2022
Competing interests
: J.H.E. and J.A. have equity interest in HDT Bio. J.H.E. is a co-inventor on U.S. patent application no. 62/993,307 “Compositions and methods for delivery of RNA” pertaining to the LION formulation. All other authors declare that they have no competing interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.